title: Type 2 innate lymphoid cells: at the cross-roads in allergic asthma.
abstract: Allergic asthma is a chronic inflammatory disease of the lower airways that affects millions of people worldwide. Allergic asthma is a T helper 2 cell (Th2)-mediated disease, in which Th2 cytokines interleukin (IL)-4, IL-5, and IL-13 are closely associated with the symptoms. IL-4 is needed by B cells to switch toward an IgE response, IL-5 recruits and activates eosinophils while IL-13 increases mucus production. The identification of type 2 innate lymphoid cells (ILC2), which are able to rapidly produce large amounts of IL-5 and IL-13 in response to epithelial derived cytokines, implicated a new key player besides Th2 cells. ILCs constitute a family of innate lymphocytes distinct from T and B cells. ILC2s are located in various epithelial compartments in mice and human, including the lung. The recent finding of increased numbers of ILC2s in the airways of severe asthma patients prompts further research to clarify their immunological function. Murine studies have shown that ILC2s are an early innate source of IL-5 and IL-13 after allergen exposure, which induce airway eosinophilic infiltration, mucus hyperproduction, and airway hyperresponsiveness but not allergen-specific IgE production. ILC2s contribute to the initiation as well as to the maintenance of the adaptive type 2 immune response. Here, we review the recent progress on our understanding of the role of ILC2s in the immunopathology of allergic asthma, in particular by studies using murine models which have elucidated fundamental mechanisms by which ILC2s act.
authors.affiliation: Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Room KO-104, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands. L.s.vanrijt@amc.uva.nl.
authors.forename: Leonie
authors.initials: L
authors.lastname: van Rijt
authors.affiliation: Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Room KO-104, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
authors.forename: Helen
authors.initials: H
authors.lastname: von Richthofen
authors.affiliation: Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Room KO-104, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.|Department of Otorhinolaryngology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
authors.forename: Ronald
authors.initials: R
authors.lastname: van Ree
mesh_terms: D056704:Adaptive Immunity; D000818:Animals; D001249:Asthma / Q000235:genetics / Q000276:immunology* / Q000378:metabolism*; D002450:Cell Communication; D016207:Cytokines / Q000378:metabolism; D004195:Disease Models, Animal; D006801:Humans; D007113:Immunity, Innate; D018836:Inflammation Mediators / Q000378:metabolism; D018793:Interleukin-13 / Q000096:biosynthesis; D015848:Interleukin-5 / Q000096:biosynthesis; D008213:Lymphocyte Activation / Q000235:genetics / Q000276:immunology; D016131:Lymphocyte Subsets / Q000276:immunology* / Q000378:metabolism*; D051379:Mice; D020545:Respiratory Mucosa / Q000276:immunology / Q000378:metabolism / Q000473:pathology
chemical_list: D016207:Cytokines; D018836:Inflammation Mediators; D018793:Interleukin-13; D015848:Interleukin-5
keywords: Allergic asthma; Type 2 immune response; Type 2 innate lymphoid cells